91. L. Qu, X. Zhang*, J. Wang, H. Zhou, T. Hou, L. Wei, F. Xu, X. Liang*, Phenotypic assessment and ligand screening of ETA/ETB receptors with label-free dynamic mass redistribution assay, Naunyn-Schmiedeberg's Archives of Pharmacology, (2019). DOI:10.1007/s00210-019-01756-6
90. R. Wang, J. Wang, Y. Liu*, X. Zhang*, X. Liang, Resonant waveguide grating based assays for colloidal aggregate detection and promiscuity characterization in natural products, RSC ADV, 9 (2019) 38055-38064. DOI:10.1039/C9RA06466D 
89. J. Deng, W. Wei, Z. Chen, B. Lin*, W. Zhao, Y. Luo, X. Zhang*,Engineered Liver-on-a-Chip Platform to Mimic Liver Functions and Its Biomedical Applications: A Review,Micromachines, 10 (2019) 676. DOI:10.3390/mi10100676
88. L. Wang, Y. Zhang, C. Wang, X. Zhang, Z. Wang, X. Liang, A. Alachkar*, O. Civelli*, A Natural Product with High Affinity to Sigma and 5-HT7 Receptors as Novel Therapeutic Drug for Negative and Cognitive Symptoms of Schizophrenia, NEUROCHEM RES, 44 (2019) 2536-2545. DOI:10.1007/s11064-019-02873-7 
87. X. Guo, Z. Gao, J. Wang, Z. Guo, X. Zhang, Y. Liu, L. Wang, C. Wang*, X. Liang*, Purification of tertiary and quaternary alkaloids from Rhizoma Corydalis using reversed-phase/weak cation-exchange mixed-mode class separation combined with preparative C18 and silica based strong cation-exchange chromatography, Journal of Chromatography B, 1126-1127 (2019) 121742. DOI:10.1016/j.jchromb.2019.121742
86. J. Wang, L. Chen, L. Qu, K. Li, Y. Zhao, Z. Wang, Y. Li, X. Zhang*, Y. Jin*, X. Liang*, Isolation and bioactive evaluation of flavonoid glycosides from Lobelia chinensis Lour using two-dimensional liquid chromatography combined with label-free cell phenotypic assays, J CHROMATOGR A, 1601 (2019) 224-231.  DOI:10.1016/j.chroma.2019.04.073 
85. J. Deng, Z. Chen, X. Zhang*, Y. Luo, Z. Wu, Y. Lu, T. Liu, W. Zhao, B. Lin*,  A liver-chip-based alcoholic liver disease model featuring multi-non-parenchymal cells,Biomedical Microdevices, 21 (2019) 57. DOI:10.1007/s10544-019-0414-9
48-2019-jiu deng-Biomedical Microdevice
84. J. Deng, X. Zhang*, Z. Chen, Y. Luo*, Y. Lu, T. Liu, Z. Wu, Y. Jin, W. Zhao, B. Lin*,  A cell lines derived microfluidic liver model for investigation of hepatotoxicity induced by drug-drug interaction,Biomicrofluidics, 13 (2019) 024101. DOI:10.1063/1.5070088
83. X. You, X. Zhang, Y. Luo*, L. Liu*, W. Zhao, B. Lin,Establishment of 3D Organ Chip for Multiplexed Assessment of Type 2 Diabetes Drugs, Progress in Biochemistry and Biophysics, 46 (2019) 620-630. DOI:10.16476/j.pibb.2018.0337
82. F. Xu, H. Zhou, X. Liu, X. Zhang*, Z. Wang, T. Hou, J. Wang, L. Qu, P. Zhang, H. Piao, X. Liang*, Label-free cell phenotypic study of FFA4 and FFA1 and discovery of novel agonists of FFA4 from natural products, Rsc Advances, 9 (2019) 15073-15083. DOI:10.1039/c9ra02142f  
81. Y. Hu, L. Yuan, X. Zhang, H. Zhou, P. Wang, G. Li, A. Wang, Y. Cong, T. Zhang, X. Liang, W. Li*, N. Li*, Production of 1,2-Cyclohexanedicarboxylates from Diacetone Alcohol and Fumarates, ACS SUSTAIN CHEM ENG, 7 (2019) 2980-2988. DOI:10.1021/acssuschemeng.8b04310